Literature DB >> 12904809

Current drug use as risk factor for erectile dysfunction: results from an Italian epidemiological study.

E Ricci1, F Parazzini, V Mirone, C Imbimbo, A Palmieri, A Bortolotti, E Di Cintio, M Landoni, M Lavezzari.   

Abstract

Several drugs have been associated with an increased risk of erectile dysfunction (ED). We analysed the role of pharmacological treatments on the risk of ED using data from a cross-sectional study on prevalence and risk factors for ED in the general population in Italy. A total of 2450 men aged more than 18 years were randomly identified by 143 general practioners (GP) among their registered patients and invited to a confidential interview by their GP. Patients were asked 'about their ability to achieve and maintain an erection sufficient for satisfactory sexual performance'. If they were dissatisfied, they were defined as having ED. Out of the 2450 men identified, 440 (18%) refused to participate. The present analysis therefore includes information on 2010 men. After adjustment for related pathologies, anxiolytics and antidepressants showed insignificantly higher odds ratio (ORs, respectively, 1.7 and 2.1); antipsychotic drug use significantly increased the risk of ED (OR 9.0, 95% confidence interval, CI 1.8-44.4). Diuretics (OR 3.1, 95% CI 1.4-6.9) and anticholinergic drugs (OR 12.8, 95% CI 2.7-60.1) were associated with ED risk. No association emerged between ED and H2 antagonists, anticholesterolemic or hypoglycemic drugs. In conclusion, after taking account of related pathologies, our results suggest that men treated with antipsychotic, diuretic and anticholinergic drugs are at greater risk of ED.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12904809     DOI: 10.1038/sj.ijir.3901008

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  6 in total

1.  Is hyperlipidemia or its treatment associated with erectile dysfunction?: Results from the Boston Area Community Health (BACH) Survey.

Authors:  Susan A Hall; Varant Kupelian; Raymond C Rosen; Thomas G Travison; Carol L Link; Martin M Miner; Peter Ganz; John B McKinlay
Journal:  J Sex Med       Date:  2009-02-09       Impact factor: 3.802

2.  Are subjects with erectile dysfunction aware of their condition? Results from a retrospective study based on an Italian free-call information service.

Authors:  A Aversa; A M Isidori; D Gianfrilli; E A Greco; A Graziottin; G Zizzo; A Lenzi; A Fabbri
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

3.  Relative contributions of modifiable risk factors to erectile dysfunction: results from the Boston Area Community Health (BACH) Survey.

Authors:  Varant Kupelian; Andre B Araujo; Gretchen R Chiu; Raymond C Rosen; John B McKinlay
Journal:  Prev Med       Date:  2009-11-24       Impact factor: 4.018

4.  Erectile dysfunction in methadone maintenance patients: a cross sectional study in northern iran.

Authors:  Seyed Hamzeh Hosseini; Ali Isapour; Mehrdad Tavakoli; Mehrdad Taghipour; Meysam Rasuli
Journal:  Iran J Psychiatry       Date:  2013-10

5.  The SAD-MEN questionnaire: a new and reliable questionnaire for assessing sexual dysfunction in Asians with diabetes.

Authors:  C M Chung; M Z H Lu; C Y T Wong; S G K Goh; M I M Azhar; Y M Lim; B N Rusli; B A K Khalid
Journal:  Diabet Med       Date:  2015-10-06       Impact factor: 4.359

Review 6.  Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach.

Authors:  Angel L Montejo; Rubén de Alarcón; Nieves Prieto; José Mª Acosta; Bárbara Buch; Laura Montejo
Journal:  J Clin Med       Date:  2021-01-15       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.